tiprankstipranks
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
Hong Kong Market
1875
TOT BIOPHARM International Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:1875 full AI Analyst Report?

TOT BIOPHARM International Co. Ltd. (1875) Financial Statements

0 Followers

TOT BIOPHARM International Co. Ltd. Financial Overview

TOT BIOPHARM International Co. Ltd.'s market cap is currently HK$3.38B. The company's EPS TTM is HK$-0.13; its P/E ratio is -16.22; TOT BIOPHARM International Co. Ltd. is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 747.64M¥ 1.10B¥ 780.63M¥ 442.18M¥ 76.33M
Gross Profit¥ 388.98M¥ 782.43M¥ 573.99M¥ 370.62M¥ 27.47M
Operating Income¥ -90.69M¥ 41.25M¥ -33.06M¥ -39.08M¥ -259.70M
EBITDA¥ -6.44M¥ 84.96M¥ 10.45M¥ -5.41M¥ -224.51M
Net Income¥ -100.37M¥ 34.76M¥ -37.76M¥ -49.92M¥ -261.22M
Balance Sheet
Cash & Short-Term Investments¥ 328.47M¥ 381.26M¥ 351.60M¥ 517.63M¥ 155.38M
Total Assets¥ 1.26B¥ 1.51B¥ 1.43B¥ 1.26B¥ 710.26M
Total Debt¥ 383.72M¥ 395.47M¥ 345.65M¥ 289.53M¥ 208.56M
Net Debt¥ 55.25M¥ 14.21M¥ -5.95M¥ -128.24M¥ 55.76M
Total Liabilities¥ 633.75M¥ 779.12M¥ 739.41M¥ 546.59M¥ 375.17M
Stockholders' Equity¥ 626.08M¥ 729.65M¥ 686.69M¥ 713.88M¥ 335.09M
Cash Flow
Free Cash Flow¥ -26.93M¥ -7.17M¥ -146.77M¥ -180.19M¥ -290.45M
Operating Cash Flow¥ 16.14M¥ 116.40M¥ 56.43M¥ 59.93M¥ -175.14M
Investing Cash Flow¥ -43.07M¥ -122.50M¥ -164.10M¥ -282.76M¥ -108.39M
Financing Cash Flow¥ -25.66M¥ 34.18M¥ 38.23M¥ 481.24M¥ 212.08M
Currency in CNY

TOT BIOPHARM International Co. Ltd. Earnings and Revenue History

Income Statement >

TOT BIOPHARM International Co. Ltd. Debt to Assets

Balance Sheet >

TOT BIOPHARM International Co. Ltd. Cash Flow

Cash Flow >

TOT BIOPHARM International Co. Ltd. Forecast EPS vs Actual EPS

Earnings >